Bolus Dosing of Alteplase in Hemodynamically Unstable Acute Pulmonary Embolism

Abstract

Get full access to this article

View all access options for this article.

References

Bernal

Fanola

Bartos

Expert analysis: management of PE. American College of Cardiology. Published January 27, 2020. Accessed June 23, 2024. https://www.acc.org/latest-in-cardiology/articles/2020/01/27/07/42/management-of-pe

Genentech. Activase (Alteplase)[packageinsert]. Genentech Inc; 2022. Accessed August 28, 2024. https://www.gene.com/download/pdf/activase_prescribing.pdf

Rivera-Lebron

Weinberg

Approach to thrombolytic (fibrinolytic) therapy in acute pulmonary embolism: patient selection and administration. UpToDate. Accessed September 16, 2024. https://www.uptodate.com/contents/approach-to-thrombolytic-fibrinolytic-therapy-in-acute-pulmonary-embolism-patient-selection-and-administration

Alteplase. Drug information. UpToDate. Updated 2024. Accessed August 28, 2024. https://www.uptodate.com/login

Levine

Hirsh

Weitz

, et al A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest. 1990;98(6):1473-1479.

Meneveau

Schiele

Metz

, et al Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol. 1998;31(5):1057-1063.

Stevens

Woller

Kreuziger

, et al Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160:e545-e608. doi:10.1016/j.chest.2021.07.055

Ortel

Neumann

Ageno

, et al American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-4738. doi:10.1182/bloodadvances.2020001830

Konstantinides

Meyer

Becattini

, et al 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405